instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'ALBUMIN HUMAN'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | 25 % | DrugDosageText | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
What was the dosage of drug 'CEFTRIAXONE SODIUM'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | 2 G, 1X/DAY | DrugDosageText | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
What was the dosage of drug 'LEVOFLOXACIN'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | 250 MG, 1X/DAY | DrugDosageText | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
What was the dosage of drug 'MEROPENEM'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | 0.5 G, 2X/DAY | DrugDosageText | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | 160 MG EVERY 8 H | DrugDosageText | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
What was the outcome of reaction 'Drug ineffective'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | Fatal | ReactionOutcome | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia Complex.
A 79-year-old man with underlying alcoholic liver cirrhosis presented with complaints of a fever, abdominal pain, and difficulty walking. A diagnostic work-up revealed liver atrophy and chylous ascites, and spon... | Fatal | ReactionOutcome | CC BY-NC-ND | 33994438 | 21,004,509 | 2021-11-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33994446 | 19,553,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DOXORUBICIN, HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33994446 | 19,366,202 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count decreased'. | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33994446 | 19,553,595 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33994446 | 19,366,202 | 2021 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | 33 MG/M2 (DAY 1) | DrugDosageText | CC BY-NC-ND | 33994446 | 19,553,595 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | 33 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC-ND | 33994446 | 19,366,202 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | 0.5 MG/DAY | DrugDosageText | CC BY-NC-ND | 33994446 | 19,553,595 | 2021 |
What was the outcome of reaction 'Platelet count decreased'? | Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remai... | Recovering | ReactionOutcome | CC BY-NC-ND | 33994446 | 19,553,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aplastic anaemia'. | Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
Cronkhite-Canada syndrome (CCS) is a rare polyposis disorder accompanied by alopecia and onychodystrophy. A 63-year-old man with a history of CCS and repeated embolism developed progressive thrombocytopenia and mild anemia. Laboratory testing, a bone marrow e... | EDOXABAN TOSYLATE, MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33994447 | 19,377,508 | 2021 |
What was the dosage of drug 'MESALAMINE'? | Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
Cronkhite-Canada syndrome (CCS) is a rare polyposis disorder accompanied by alopecia and onychodystrophy. A 63-year-old man with a history of CCS and repeated embolism developed progressive thrombocytopenia and mild anemia. Laboratory testing, a bone marrow e... | 2000MG/DAY | DrugDosageText | CC BY-NC-ND | 33994447 | 19,377,508 | 2021 |
What was the outcome of reaction 'Aplastic anaemia'? | Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
Cronkhite-Canada syndrome (CCS) is a rare polyposis disorder accompanied by alopecia and onychodystrophy. A 63-year-old man with a history of CCS and repeated embolism developed progressive thrombocytopenia and mild anemia. Laboratory testing, a bone marrow e... | Recovering | ReactionOutcome | CC BY-NC-ND | 33994447 | 19,377,508 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | A Case of Joubert Syndrome with Chronic Kidney Disease.
Joubert syndrome is a genetically heterogeneous disorder that belongs to the group of cerebello-oculo-renal syndromes. It is characterised by neurodevelopmental abnormalities and complex midbrain-hindbrain malformation, visible on brain imaging as a molar tooth si... | LEVETIRACETAM | DrugsGivenReaction | CC BY-NC-SA | 33994691 | 19,161,011 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Case of Joubert Syndrome with Chronic Kidney Disease.
Joubert syndrome is a genetically heterogeneous disorder that belongs to the group of cerebello-oculo-renal syndromes. It is characterised by neurodevelopmental abnormalities and complex midbrain-hindbrain malformation, visible on brain imaging as a molar tooth si... | LEVETIRACETAM | DrugsGivenReaction | CC BY-NC-SA | 33994691 | 19,161,011 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | A Case of Joubert Syndrome with Chronic Kidney Disease.
Joubert syndrome is a genetically heterogeneous disorder that belongs to the group of cerebello-oculo-renal syndromes. It is characterised by neurodevelopmental abnormalities and complex midbrain-hindbrain malformation, visible on brain imaging as a molar tooth si... | LEVETIRACETAM | DrugsGivenReaction | CC BY-NC-SA | 33994691 | 19,161,011 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
Adverse drug reactions (ADRs) are an important and frequent cause of morbidity and mortality. ADR can be related to a variety of drugs, including anticonvulsants, anaesthetics, antibiotics, antiretroviral, anticancer, and antia... | PAROXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33995067 | 20,042,140 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular tachycardia'. | Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
Adverse drug reactions (ADRs) are an important and frequent cause of morbidity and mortality. ADR can be related to a variety of drugs, including anticonvulsants, anaesthetics, antibiotics, antiretroviral, anticancer, and antia... | PAROXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33995067 | 20,042,140 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileus paralytic'. | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33995251 | 19,395,773 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelitis transverse'. | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33995251 | 19,395,773 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33995251 | 19,332,387 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33995251 | 19,332,387 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 33995251 | 19,332,387 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | 2 MILLIGRAM/KILOGRAM, Q3W | DrugDosageText | CC BY | 33995251 | 19,395,773 | 2021 |
What was the outcome of reaction 'Myelitis transverse'? | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | Recovering | ReactionOutcome | CC BY | 33995251 | 19,395,773 | 2021 |
What was the outcome of reaction 'Sepsis'? | Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab.
A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) t... | Fatal | ReactionOutcome | CC BY | 33995251 | 19,332,387 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device related sepsis'. | Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
In immunocompromised patients, EBV may elicit B-cell transformation and proliferation. A 5-year-old microcephalic boy was admitted with fever and non-malignant polymorphic T-cell lymphoproliferativ... | CYCLOPHOSPHAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 33995370 | 19,963,366 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
In immunocompromised patients, EBV may elicit B-cell transformation and proliferation. A 5-year-old microcephalic boy was admitted with fever and non-malignant polymorphic T-cell lymphoproliferativ... | CYCLOPHOSPHAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 33995370 | 20,088,702 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
In immunocompromised patients, EBV may elicit B-cell transformation and proliferation. A 5-year-old microcephalic boy was admitted with fever and non-malignant polymorphic T-cell lymphoproliferativ... | CYCLOPHOSPHAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 33995370 | 20,088,702 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
In immunocompromised patients, EBV may elicit B-cell transformation and proliferation. A 5-year-old microcephalic boy was admitted with fever and non-malignant polymorphic T-cell lymphoproliferativ... | CYCLOPHOSPHAMIDE, RITUXIMAB | DrugsGivenReaction | CC BY | 33995370 | 20,088,702 | 2021 |
What was the outcome of reaction 'Device related sepsis'? | Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
In immunocompromised patients, EBV may elicit B-cell transformation and proliferation. A 5-year-old microcephalic boy was admitted with fever and non-malignant polymorphic T-cell lymphoproliferativ... | Fatal | ReactionOutcome | CC BY | 33995370 | 19,963,366 | 2021 |
What was the outcome of reaction 'Disease recurrence'? | Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
In immunocompromised patients, EBV may elicit B-cell transformation and proliferation. A 5-year-old microcephalic boy was admitted with fever and non-malignant polymorphic T-cell lymphoproliferativ... | Fatal | ReactionOutcome | CC BY | 33995370 | 20,088,702 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angina pectoris'. | Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study).
BACKGROUND
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed ... | ALDOSTERONE, ASPIRIN, EVOLOCUMAB | DrugsGivenReaction | CC BY-NC-SA | 33995505 | 19,794,333 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arterial revascularisation'. | Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study).
BACKGROUND
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed ... | ALDOSTERONE, ASPIRIN, EVOLOCUMAB | DrugsGivenReaction | CC BY-NC-SA | 33995505 | 19,794,333 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiovascular disorder'. | Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study).
BACKGROUND
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed ... | ALDOSTERONE, ASPIRIN, EVOLOCUMAB | DrugsGivenReaction | CC BY-NC-SA | 33995505 | 19,794,333 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial infarction'. | Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study).
BACKGROUND
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed ... | ALDOSTERONE, ASPIRIN, EVOLOCUMAB | DrugsGivenReaction | CC BY-NC-SA | 33995505 | 19,794,333 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Unevaluable event'. | Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study).
BACKGROUND
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed ... | ALDOSTERONE, ASPIRIN, EVOLOCUMAB | DrugsGivenReaction | CC BY-NC-SA | 33995505 | 19,794,333 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | MESALAMINE | DrugsGivenReaction | CC BY | 33995584 | 19,383,074 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis'. | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | MESALAMINE | DrugsGivenReaction | CC BY | 33995584 | 19,394,577 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33995584 | 19,715,880 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | CIPROFLOXACIN, HYDROXYCHLOROQUINE, MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33995584 | 19,742,084 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | CIPROFLOXACIN, HYDROXYCHLOROQUINE, MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33995584 | 19,742,084 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | CIPROFLOXACIN, HYDROXYCHLOROQUINE, MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33995584 | 19,742,084 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33995584 | 19,742,084 | 2021 |
What was the outcome of reaction 'Colitis ulcerative'? | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | Recovered | ReactionOutcome | CC BY | 33995584 | 19,383,074 | 2021 |
What was the outcome of reaction 'Colitis'? | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | Recovering | ReactionOutcome | CC BY | 33995584 | 19,394,577 | 2021 |
What was the outcome of reaction 'Myocarditis'? | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | Recovered | ReactionOutcome | CC BY | 33995584 | 19,742,084 | 2021 |
What was the outcome of reaction 'Rebound effect'? | Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
In the wake of the coronavirus disease 2019 (COVID-19) pandemic, it is unclear how asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients who pres... | Recovered | ReactionOutcome | CC BY | 33995584 | 19,742,084 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of pat... | CISPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY-NC | 33995588 | 19,315,536 | 2021 |
What was the dosage of drug 'FLUOROURACIL'? | Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of pat... | 5?FLUOROURACIL?SIX CYCLES | DrugDosageText | CC BY-NC | 33995588 | 19,280,580 | 2021 |
What was the dosage of drug 'FULVESTRANT'? | Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of pat... | 11 CYCLES | DrugDosageText | CC BY-NC | 33995588 | 19,280,580 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of pat... | 12 CYCLES FOLLOWED BY SIX CYCLES OF 5?FLUOROURACIL | DrugDosageText | CC BY-NC | 33995588 | 19,280,580 | 2021 |
What was the dosage of drug 'PALBOCICLIB'? | Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of pat... | 11 CYCLES | DrugDosageText | CC BY-NC | 33995588 | 19,280,580 | 2021 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of pat... | RADIATION THERAPY?50GY IN 25 FRACTIONS TO THE LEFT CENTRAL CHEST AND LEFT LATERAL CHEST WALL WITH AN | DrugDosageText | CC BY-NC | 33995588 | 19,280,580 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection.
Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus di... | BEVACIZUMAB, FLUOROURACIL SODIUM, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33995596 | 19,397,063 | 2021 |
What was the dosage of drug 'LEUCOVORIN'? | Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection.
Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus di... | 400 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 33995596 | 19,397,063 | 2021 |
What was the dosage of drug 'OXALIPLATIN'? | Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection.
Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus di... | 85 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC | 33995596 | 19,397,063 | 2021 |
What was the outcome of reaction 'COVID-19'? | Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection.
Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus di... | Recovered | ReactionOutcome | CC BY-NC | 33995596 | 19,397,063 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | BRAF p.V600E associated poly-neoplastic syndrome.
We report a male patient who developed eight different cancers between ages 57 and 64. BRAF p.V600E mutation was detected in Langerhans cell histiocytosis, chronic lymphocytic leukemia, histiocytic sarcoma, melanoma, and adenocarcinoma of the lung. It was not detected i... | DABRAFENIB, TRAMETINIB | DrugsGivenReaction | CC BY-NC | 33995981 | 19,488,579 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | BRAF p.V600E associated poly-neoplastic syndrome.
We report a male patient who developed eight different cancers between ages 57 and 64. BRAF p.V600E mutation was detected in Langerhans cell histiocytosis, chronic lymphocytic leukemia, histiocytic sarcoma, melanoma, and adenocarcinoma of the lung. It was not detected i... | DABRAFENIB, TRAMETINIB | DrugsGivenReaction | CC BY-NC | 33995981 | 19,488,579 | 2021 |
What was the administration route of drug 'DABRAFENIB'? | BRAF p.V600E associated poly-neoplastic syndrome.
We report a male patient who developed eight different cancers between ages 57 and 64. BRAF p.V600E mutation was detected in Langerhans cell histiocytosis, chronic lymphocytic leukemia, histiocytic sarcoma, melanoma, and adenocarcinoma of the lung. It was not detected i... | Oral | DrugAdministrationRoute | CC BY-NC | 33995981 | 19,488,579 | 2021 |
What was the administration route of drug 'TRAMETINIB'? | BRAF p.V600E associated poly-neoplastic syndrome.
We report a male patient who developed eight different cancers between ages 57 and 64. BRAF p.V600E mutation was detected in Langerhans cell histiocytosis, chronic lymphocytic leukemia, histiocytic sarcoma, melanoma, and adenocarcinoma of the lung. It was not detected i... | Oral | DrugAdministrationRoute | CC BY-NC | 33995981 | 19,488,579 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | AZITHROMYCIN | DrugsGivenReaction | CC BY-NC | 33995989 | 20,098,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukocytosis'. | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | AZITHROMYCIN | DrugsGivenReaction | CC BY-NC | 33995989 | 20,098,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | AZITHROMYCIN | DrugsGivenReaction | CC BY-NC | 33995989 | 20,098,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | AZITHROMYCIN | DrugsGivenReaction | CC BY-NC | 33995989 | 20,098,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | AZITHROMYCIN | DrugsGivenReaction | CC BY-NC | 33995989 | 20,098,467 | 2021 |
What was the outcome of reaction 'Anaemia'? | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | Recovered | ReactionOutcome | CC BY-NC | 33995989 | 20,098,467 | 2021 |
What was the outcome of reaction 'Leukocytosis'? | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | Recovered | ReactionOutcome | CC BY-NC | 33995989 | 20,098,467 | 2021 |
What was the outcome of reaction 'Lymphopenia'? | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | Recovered | ReactionOutcome | CC BY-NC | 33995989 | 20,098,467 | 2021 |
What was the outcome of reaction 'Thrombocytopenia'? | Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against p... | Recovered | ReactionOutcome | CC BY-NC | 33995989 | 20,098,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,783,120 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,783,120 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,750,797 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,750,797 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,783,120 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal motility disorder'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,750,797 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal transit time abnormal'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,750,797 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,750,797 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Mucosal urinary secretion revealing adenocarcinoma of urachus.
Urachus adenocarcinoma is an extremely rare malignant tumor characterized by its insidious evolution responsible for the delay in diagnosis. Several scientific works have tried to study the indication of adjuvant treatment, therefore the prognosis is still ... | FLUOROURACIL, FOLIC ACID, OXALIPLATIN | DrugsGivenReaction | CC BY | 33996065 | 19,750,797 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | ALFUZOSIN HYDROCHLORIDE, CHOLECALCIFEROL, DIMETHYL FUMARATE, OMEPRAZOLE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 33996142 | 12,395,888 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | ALFUZOSIN HYDROCHLORIDE, CHOLECALCIFEROL, DIMETHYL FUMARATE, OMEPRAZOLE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 33996142 | 12,395,888 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Progressive multifocal leukoencephalopathy'. | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | ALFUZOSIN HYDROCHLORIDE, CHOLECALCIFEROL, DIMETHYL FUMARATE, OMEPRAZOLE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 33996142 | 12,395,888 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spinal fracture'. | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | ALFUZOSIN HYDROCHLORIDE, CHOLECALCIFEROL, DIMETHYL FUMARATE, OMEPRAZOLE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What is the weight of the patient? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | 67.19 kg. | Weight | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the administration route of drug 'ALFUZOSIN HYDROCHLORIDE'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Other | DrugAdministrationRoute | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the administration route of drug 'CHOLECALCIFEROL'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Other | DrugAdministrationRoute | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the administration route of drug 'DIMETHYL FUMARATE'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Other | DrugAdministrationRoute | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the administration route of drug 'OMEPRAZOLE'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Other | DrugAdministrationRoute | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the administration route of drug 'ZOLPIDEM TARTRATE'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Other | DrugAdministrationRoute | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the dosage of drug 'DIMETHYL FUMARATE'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | MAINTENANCE DOSE | DrugDosageText | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the outcome of reaction 'Intentional product use issue'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Recovered | ReactionOutcome | CC BY-NC | 33996142 | 12,395,888 | 2021 |
What was the outcome of reaction 'Progressive multifocal leukoencephalopathy'? | Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis.
There is limited data analyzing the safety and effectiveness of dimethyl fumarate (DMF) in the progressive multiple sclerosis (PMS) population.
To analyze the safety and effectiveness of DMF in patients with PMS.
We used Cox proportional h... | Not recovered | ReactionOutcome | CC BY-NC | 33996142 | 12,395,888 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature.
Radiation recall pneumonitis (RRP) is a poorly understood clinical syndrome in which patients develop radiation pneumonitis triggered by a systemic agent, often years after the completion of radi... | DOCETAXEL | DrugsGivenReaction | CC BY | 33996587 | 19,594,173 | 2021 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Posttransplant lymphoproliferative disorder (PTLD) is a rare complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) with poor p... | Oral | DrugAdministrationRoute | CC BY | 33996600 | 19,614,379 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.